Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00790517 · ClinicalTrials.gov registry record · Phase 2
Reducing Weight and Diabetes Risk in an Underserved Population (STRIDE)
A Phase 2 study, sponsored by Kaiser Permanente.
- Completed
- Registry status
- Phase 2
- Development phase
- 200
- Enrollment target
NCT00790517 is a Phase 2 study that has completed, run by Kaiser Permanente. The registered enrollment target is 200 participants.
The verdict
NCT00790517, a Phase 2 study, has completed, sponsored by Kaiser Permanente.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 200 participants
- Enrollment target
Study Summary
The purpose of this study is to examine the effectiveness of a lifestyle intervention designed to reduce weight and diabetes risk in a population of individuals with mental illness who are also taking antipsychotic medications. We will examine the effectiveness of the intervention in 1. reducing weight and Body Mass Index; 2. reducing fasting insulin levels and increasing insulin sensitivity; and 3. reducing total cholesterol and LDL cholesterol.
Interventions
- BEHAVIORAL Premier Lifestyle Intervention with DASH Diet
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2009-06 |
| Est. Completion | 2014-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00790517
The ClinicalTrials.gov registry entry for NCT00790517 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Kaiser Permanente, which has 294 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Premier Lifestyle Intervention with DASH Diet is the first listed.
NCT00790517 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00790517 about?
NCT00790517 is a clinical study titled "Reducing Weight and Diabetes Risk in an Underserved Population (STRIDE)". The purpose of this study is to examine the effectiveness of a lifestyle intervention designed to reduce weight and diabetes risk in a population of individuals with mental illness who are also taking antipsychotic medications. We will examine the effectiveness of the intervention in 1. reducing we...
What is the current status of trial NCT00790517?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 200 participants. The study started on 2009-06. Estimated completion is 2014-12.
What interventions are being tested in trial NCT00790517?
The interventions under investigation include: Premier Lifestyle Intervention with DASH Diet (BEHAVIORAL).
Who is sponsoring clinical trial NCT00790517?
This trial is sponsored by Kaiser Permanente, which has 294 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.